Skip to content
Home » Medicine » COVID-19 » Page 2

COVID-19

pregnancy COVID-19 vaccine

COVID-19 vaccine during pregnancy – the CDC now recommends it

The CDC endorses the COVID-19 vaccine for pregnant individuals based on a study showing no significant safety concerns. Research involving 35,691 pregnant participants found typical vaccination symptoms and no evidence of increased risk for adverse pregnancy outcomes. The findings suggest the vaccine’s efficacy and safety during pregnancy, reinforcing its importance for maternal and fetal health.

brown wooden gavel on brown wooden table

January 6 rioter Simone Gold reprimanded by medical board

Simone Gold, a leader of America’s Frontline Doctors, pled guilty to charges from the January 6 insurrection and was sentenced to 60 days in prison plus supervised release. She’s facing legal challenges, including an accusation of unprofessional conduct by the Medical Board of California. Additionally, Gold is accused of misusing funds for personal gain and implicated in a lawsuit concerning a patient’s death involving hydroxychloroquine. She retains her medical licenses in California and Florida.

COVID-19 vaccines diabetes

Do COVID vaccines cause diabetes? Another anti-vax myth

Anti-vaxxers falsely claim COVID-19 vaccines cause diabetes, ignoring that the virus itself may increase diabetes risk. Diabetes, characterized by high blood sugar, comes in Type 1 (autoimmune) and Type 2 (often lifestyle-related). COVID-19 vaccines can briefly raise blood sugar, a minor issue compared to their protective benefits. No evidence supports vaccines causing diabetes, while COVID-19 has a proven link to the disease.

COVID-19 hair loss

Large study shows that COVID-19 is linked to hair loss

Recent research published in JAMA Dermatology suggests a connection between COVID-19 and an increased risk of alopecia areata, an autoimmune hair loss condition. A cohort study, including over half a million matched patients, indicates higher autoimmune disease incidence, such as alopecia, in patients who have had COVID-19, providing another incentive for vaccination.

JN.1 COVID variant

JN.1 variant of COVID update

The JN.1 COVID-19 variant, a subvariant of Omicron, is rapidly spreading in the USA. While it may evade immunity from vaccines or previous infection, current vaccines appear effective against it. It poses a greater risk to the unvaccinated. Public health agencies are closely monitoring its transmission and severity to prevent potential disasters. COVID-19 remains a significant threat.